Oxonic Acid: all 185 studies that test it
Page 1 of 2. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.
- DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric CancerNot yet recruitingNCT07757191Phase 2
- Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRecruitingNCT07569068Phase 2
- LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory StudyRecruitingNCT07556640Phase 2
- Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction CancerRecruitingNCT07522151Phase 3
- Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07507916Phase 2
- IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT07483567Phase 2
- Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical TrialRecruitingNCT07474324Phase 2
- Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric CancerRecruitingNCT07366528Phase 3
- A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10Not yet recruitingNCT07304258Phase 2
- Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II TrialRecruitingNCT07070479Phase 2
- Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric CancerRecruitingNCT07007182Phase 2
- Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaEnrolling by invitationNCT06901622Phase 2
- Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular SubtypingNot yet recruitingNCT06881017Phase 2
- Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic CancerRecruitingNCT06789679Phase 2
- Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/MetastasisNot yet recruitingNCT06779318Phase 4
- A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer.Not yet recruitingNCT06746545Phase 2
- Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRTNot yet recruitingNCT06598917Phase 2
- Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal MetastasisRecruitingNCT06519591Phase 2
- Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric CancerRecruitingNCT06451211Phase 2
- AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ CancerRecruitingNCT06196697Phase 2
- Tislelizumab Plus Concurrent Chemoradiation in Older With ESCCRecruitingNCT06061146Phase 2
- To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Not yet recruitingNCT05948449Phase 2
- Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC DetectionNot yet recruitingNCT05720559Phase 2
- Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric AdenocarcinomaRecruitingNCT05237349Phase 2
- Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic CancerRecruitingNCT05218889Phase 1/2
- A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric CancerRecruitingNCT05184803Phase 2
- The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.RecruitingNCT05170542Phase 2
- Peri-operative SLOG for Localized Pancreatic CancerRecruitingNCT05048524Phase 2
- Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction CancerRecruitingNCT04999332Phase 2
- Diffuse Gastric and Esophagogastric Junction Cancer S-1 TrialTerminatedNCT01285557Phase 3Results posted
- Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical CancerCompletedNCT00770874Phase 3Results posted
- Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic CancerCompletedNCT00651742Phase 2Results posted
- Capecitabine vs. S-1 in Unresectable or Recurrent Breast CancerCompletedNCT00438100Phase 2Results posted
- A Safety and Efficacy Study in Patients With Gastric CancerCompletedNCT00400179Phase 3Results posted
- Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized TrialCompletedNCT00278863Phase 2Results posted
- A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 ExpressionActive, not recruitingNCT06939452Phase 2
- Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT06914687Phase 2
- Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric JunctionActive, not recruitingNCT06576921Phase 2
- Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm StudyActive, not recruitingNCT05602935Phase 2
- Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung CancerStatus unknownNCT05529355Phase 2
- Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric CancerStatus unknownNCT05519202Phase 2
- Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical StudyStatus unknownNCT05441254Phase 2
- Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT05204173Phase 2
- Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic CancerStatus unknownNCT04808687Phase 2
- Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric CancerStatus unknownNCT04694404Phase 2
- Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaStatus unknownNCT04319471Phase 2
- Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric CancerStatus unknownNCT04258657Phase 2
- Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric CancerStatus unknownNCT04258644Phase 2
- Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT04221555Phase 2
- A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in TaiwanTerminatedNCT04070313Phase 2
- A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric CancerStatus unknownNCT04062058Phase 2
- Second Line Treatment With Nal-IRI and S1 in Pancreatic CancerStatus unknownNCT03986294Phase 2
- Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric CancerStatus unknownNCT03950141Phase 2
- Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT03885219Phase 2
- Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerStatus unknownNCT03850769Phase 2
- The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract AdenocarcinomaCompletedNCT03830606Phase 2
- A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )Status unknownNCT03825328Phase 2
- S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung CancerCompletedNCT03823118Phase 2
- Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic CancerStatus unknownNCT03815461Phase 2
- Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric AdenocarcinomaCompletedNCT03814759Phase 2
- Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric AdenocarcinomaStatus unknownNCT03801668Phase 3
- Maintenance Therapy for Small-cell Lung CancerCompletedNCT03769935Phase 2
- Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal AdenocarcinomaWithdrawnNCT03708536Phase 3
- Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric AdenocarcinomaActive, not recruitingNCT03691454Phase 2/3
- S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03668366Phase 2
- Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT03559348Phase 2
- TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRCCompletedNCT03517618Phase 2
- S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLCStatus unknownNCT03457337Phase 2
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
- Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric CancerStatus unknownNCT03427684Phase 1/2
- Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerCompletedNCT03415802Phase 2
- Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal CancerStatus unknownNCT03397199Phase 2
- Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine CarcinomaStatus unknownNCT03279614Phase 2
- Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT03276156Phase 1
- Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerStatus unknownNCT03263741Phase 2
- Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial TractCompletedNCT03051373Phase 2
- Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01CompletedNCT02979691Phase 2/3
- Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric CancerStatus unknownNCT02949258Phase 2
- S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast CancerStatus unknownNCT02947061Phase 2
- Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic CancerStatus unknownNCT02945267Phase 4
- A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT02878889Phase 2
- SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal CancerStatus unknownNCT02870153Phase 2
- Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerTerminatedNCT02867839Phase 3
- S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal CancerCompletedNCT02813967Phase 3
- S-1 and Radiotherapy for Elderly Esophageal Cancer PatientsWithdrawnNCT02716688Phase 2
- Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerStatus unknownNCT02688023Phase 2
- Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver MetastasisStatus unknownNCT02634502Phase 2
- Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal CancerStatus unknownNCT02618356Phase 2
- Endobiliary Radiofrequency Ablation With S-1 for Unresectable CholangiocarcinomaCompletedNCT02592538Not applicable
- Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric JunctionCompletedNCT02564367Phase 1/2
- Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract CancerStatus unknownNCT02527824Phase 2
- Study of Oxaliplatin, Irinotecan, and S-1 in Gastric CancerCompletedNCT02527785Phase 2
- Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) CancerStatus unknownNCT02512380Phase 3
- Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic CancerCompletedNCT02459652Phase 2
- TOF Versus SOX in Metastatic Gastric CancerCompletedNCT02442362Phase 2/3
- A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract CancerCompletedNCT02425137Phase 2
- Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal CancerCompletedNCT02347904Phase 1
- A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric AdenocarcinomaCompletedNCT02301481Phase 2
- A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric CancerStatus unknownNCT02296658Phase 2
- RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).Status unknownNCT02280070Phase 2